facebook
twitter
rss
account
search
search
 

FDA: Diabetes drug may up cancer risk

July 16, 2011 at 7:03 PM   |   Comments

WASHINGTON, July 16 (UPI) -- A diabetes drug under development may be linked to bladder and breast cancer, the U.S. Food and Drug Administration says.

During clinical trials, nine cases of each type of cancer were reported among patients taking dapagliflozin and only one of each among patients on the placebo, Medical News Today reported Friday.

An advisory panel is to meet Tuesday to consider the drug, which was developed jointly by Bristol-Myers Squibb Co. and AstraZeneca. The companies say they expect action from the FDA within the next few months.

In a report released Friday, the FDA said the drug appears to be effective at treating diabetes. In addition to the increased number of cancer cases, the FDA said dapagliflozin appeared to increase the risk of liver damage, urinary and genital infections and bone loss, and was less effective in patients with damaged kidneys.

Rosiglitazone, a diabetes drug marketed as Avandia by Glaxo Smith Kline, was linked to an increased risk of heart attacks in 2007 after it had been approved by the FDA. Avandia is still sold in the United States but increased controls are to take effect this fall.

© 2011 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Most Popular
1
Schizophrenia is actually eight disorders, not one disease Schizophrenia is actually eight disorders, not one disease
2
Study: too many kids taking antibiotics Study: too many kids taking antibiotics
3
NFL players have 30 percent chance of developing Alzheimer's or dementia NFL players have 30 percent chance of developing Alzheimer's or dementia
4
Morning exercise helps calm ADHD symptoms in children Morning exercise helps calm ADHD symptoms in children
5
Yoga guru BKS Iyengar dies at 95 Yoga guru BKS Iyengar dies at 95
Trending News
Video
x
Feedback